Skip to search formSkip to main contentSkip to account menu

recombinant human thrombopoietin

Known as: rhTPO, thrombopoietin, recombinant human, Recombinant Human TPO 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Recombinant human thrombopoietin (rhTPO) is a key determinant of therapy for chemotherapy-induced thrombocytopenia (CIT) in… 
Review
2009
Review
2009
Thrombopoietin (TPO) is the major regulator of both megakaryopoiesis and platelet production. TPO is a glycoprotein primarily… 
2008
2008
OBJECTIVE To evaluate the efficacy and safety of recombinant human thrombopoietin (rhTPO) in treatment for chemotherapy-induced… 
2002
2002
This phase I/II dose-escalation study examined the safety and efficacy of recombinant human thrombopoietin (rhTPO) and… 
2001
2001
Recombinant human thrombopoietin (rhTPO) is a full-length glycosylated molecule that has been under evaluation in the setting of… 
1997
1997
A heterogeneity in the molecular weight (Mr) of thrombopoietin (TPO) has been reported. We found several thrombin cleavage sites… 
1997
1997
Abstract: Thrombopoietin (TPO) is a ligand for c‐mpl that promotes both proliferation and differentiation of megakaryocytes in… 
1996
1996
Thrombopoietin (TPO) is implicated as a primary regulator of megakaryopoiesis and thrombopoiesis. However, the biologic effects… 
1996
1996
The recently cloned factor thrombopoietin (TPO) has been shown to exhibit megakaryocyte colony-stimulating activity in vitro. In…